MetaADEDB 2.0 @ LMMD
pipamperone
(AXKPFOAXAHJUAG-UHFFFAOYSA-N)
Structure
SMILES
O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N
Type(s)
Investigational
ATC code(s)
N05AD05
Molecular Formula:
C21H30FN3O2
Molecular Weight:
375.480
Log P:
3.1705
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
1
TPSA:
66.64
CAS Number(s):
1893-33-0
Synonym(s)
1.
pipamperone
2.
1'-(3-(4-fluorobenzoyl)propyl)-(1,4'-bipiperidine) -4'-carboxamide
3.
Dipiperon
4.
Pipamperon-neuraxpharm
5.
R 3345
6.
pipamperone dihydrochloride
External Link(s)
MeSHC005569
PubChem Compound4830
BindingDB81483
ChEBI78549
CHEMBLCHEMBL440294
DrugBankDB09286
DrugCentral2181
IUPHAR/BPS Guide to PHARMACOLOGY92
KEGGdr:D02622
Therapeutic Target DatabaseD00DBO
ZINC21297287
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abnormal weight gainOFFSIDES
2AbuseOFFSIDES
3Accidental drug intake by childOFFSIDES
4Accidental exposureOFFSIDES
5AcidosisOFFSIDES
6AkinesiaOFFSIDES
7AlbuminuriaOFFSIDES
8Alcohol poisoningOFFSIDES
9AnuriaOFFSIDES
10AtaxiaOFFSIDES
11Atrioventricular extrasystolesOFFSIDES
12Basal Ganglia Diseases11549212CTD
13Blood creatinine increasedOFFSIDES
14Blood erythropoietin increasedOFFSIDES
15Blood potassium decreasedOFFSIDES
16Blood potassium increasedOFFSIDES
17Blood sodium increasedOFFSIDES
18Blood sodiumOFFSIDES
19Blood uric acidOFFSIDES
20Body TemperatureOFFSIDES
21BradycardiaOFFSIDES
22BronchitisOFFSIDES
23Bulbar palsyOFFSIDES
24Cardiovascular insufficiencyOFFSIDES
25CatatoniaOFFSIDES
26Catheter related infectionOFFSIDES
27Cell DeathOFFSIDES
28Cerebral atrophyOFFSIDES
29Chemotherapeutic drug level increasedOFFSIDES
30Completed SuicideOFFSIDES
31Cor pulmonaleOFFSIDES
32DehydrationOFFSIDES
33DrowsinessOFFSIDES
34Drug abuserOFFSIDES
35Dysthymic DisorderOFFSIDES
36Electrocardiogram QT corrected intervalOFFSIDES
37EpilepsyOFFSIDES
38ErysipelasOFFSIDES
39GalactorrheaOFFSIDES
40GammopathyOFFSIDES
41Gastrointestinal sounds abnormalOFFSIDES
42General physical health deteriorationOFFSIDES
43GlobulinuriaOFFSIDES
44HemiplegiaOFFSIDES
45HyperparathyroidismOFFSIDES
46Hypertensive heart diseaseOFFSIDES
47HyperventilationOFFSIDES
48Hyperviscosity syndromeOFFSIDES
49HypokinesiaOFFSIDES
50ImmobileOFFSIDES
51Inappropriate schedule of drug administrationOFFSIDES
52Incision site infectionOFFSIDES
53Leukopenia neonatalOFFSIDES
54LipaseOFFSIDES
55MeningoceleOFFSIDES
56Mental disorders16856516CTD
57Metastatic NeoplasmOFFSIDES
58MicrocephalyOFFSIDES
59MoaningOFFSIDES
60Multiple MyelomaOFFSIDES
61Multiple drug overdose intentionalOFFSIDES
62MutismOFFSIDES
63Neuroleptic Malignant SyndromeOFFSIDES
64OverdoseOFFSIDES
65PROTHROMBIN TIMEOFFSIDES
66PallorOFFSIDES
67Panic DisorderOFFSIDES
68ParaparesisOFFSIDES
69PeriodontitisOFFSIDES
70Personality ChangeOFFSIDES
71Renal tubular necrosisOFFSIDES
72ReticulocytopeniaOFFSIDES
73RhabdomyolysisOFFSIDES
74Septic ShockOFFSIDES
75SoporOFFSIDES
76Spina BifidaOFFSIDES
77Strawberry tongueOFFSIDES
78SubileusOFFSIDES
79ThrombophlebitisOFFSIDES
80TracheobronchitisOFFSIDES
81Umbilical herniaOFFSIDES
82Vascular encephalopathyOFFSIDES
83Vitamin A DeficiencyOFFSIDES
84Wrong drug administeredOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.